The race to commercialize biotechnology: Molecules, market and the state in Japan and the US

The Race to Commercialize Biotechnology: Molecules, Market and the State in Japan and the US

Volumn , Issue , 2004, Pages 1-191

  Collins, Steven W ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84909134700     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4324/9780203642719     Document Type: Book

References (180)

1. Kenichi Arai, Tokyo genomu bei keikaku [Tokyo Genome Bay Project], Tokyo: Kodansha, 2002, p. 36.
2. R. Triendl, "Large-Scale Projects See Increased Spending in Japan's Budget," Nature Biotechnology, March 2003, p. 218.
3. "Alleged Biotech Espionage Rocks Japan," The Lancet, 20 June 2001, vol. 357, p. 2111.
4. "Idenshi supai jiken de shintenkai" [New Developments in Gene Spy Case], Nikkei Baiobijinesu, January 2003, p. 23
5. "Espionage Charges Threaten to Undermine Research Relations," Nature, 17 May 2001, pp. 225-6.
6. "Scientists Jailed for Alleged Theft from Harvard Laboratory," Nature, 27 June 2002, p. 886.
7. "'Tokkyo arasoi' no kanetsu ga haikei ni" [Overheating of Patent Wars in the Background], Nihon Keizai Shimbun, 19 July 2002.
8. "Shinyaku supai, bei piripiri" [America Stung by New Drug Spy], Yomiuri Shimbun, 21 June 2002
9. "Chiteki zaisan hogo: Nihon okureru hoseibi" [Protecting Intellectual Property: Japan Lags in Revising Law], Yomiuri Shimbun, 21 June 2002.
10. "Mapping the Human Genome: Patent Setbacks Hamper Japan in Life Sciences," Daily Yomiuri, 7 August 2000, p. 1.
11. R.J. Samuels, Rich Nation, Strong Army: National Security and the Technological Transformation of Japan, Ithaca, NY: Cornell University Press, 1994.
12. "Keizai sangyosho, Seibutsu kagaku sangyoka, Baiotekunoroji-senryaku taiko no torimatome ni tsuite" [Regarding the Outline on Biotechnology Strategy], April 2003, p. 8, online, available HTTP: (accessed 26 April 2003).
13. Ernst & Young, "Global Biotechnology at a Glance," online, available HTTP: (accessed 16 May 2003).
14. S. Casper, "Institutional Adaptiveness, Technology Policy, and the Diffusion of New Business Models: The Case of German Biotechnology," Organization Studies, 2000, vol. 21, 887-914
15. H. Ergas, "Does Technology Policy Matter?" in B. Guile and H. Brooks (eds) Technology and Global Industry: Companies and Nations in the World Economy, Washington, DC: National Academy Press, 1987
16. P.A. Hall and D. Soskice (eds) Varieties of Capitalism: The Institutional Foundations of Comparative Advantage, New York: Oxford University Press, 2001
17. J.R. Hollingsworth, W.S. Schmitter, and W. Streeck (eds) Governing Capitalist Economies, New York: Oxford University Press, 1994.
18. B. Achilladelis and N. Antonakis, "The Dynamics of Technological Innovation: The Case of the Pharmaceutical Industry," Research Policy, 2001, vol. 30, 535-88
19. M. Kenney, Biotechnology: The University-Industrial Complex, New Haven, CN: Yale University Press, 1986
20. L.H. Lynn, N.M. Reddy, and J.D. Aram, "Linking Technology and Institutions: The Innovation Community Framework," Research Policy, 1996, vol. 25, 91-106
21. M.D. McKelvey, Evolutionary Innovations: The Business of Biotechnology, New York: Oxford University Press, 1996
22. W. Powell, "Learning from Collaboration: Knowledge and Networks in the Biotechnology and Pharmaceutical Industries," California Management Review, 1998, vol. 40, 228-40
23. D. Teece (ed.) The Competitive Challenge, Cambridge, MA: Ballinger, 1987.
24. H. Gottweis, Governing Molecules: The Discursive Politics of Genetic Engineering in Europe and the United States, Cambridge, MA: MIT Press, 1998
25. S. Wright, Molecular Politics: Developing American and British Regulatory Policy for Genetic Engineering, 1972-1982, Chicago: University of Chicago Press, 1994.
26. S. Coleman, Japanese Science: From the Inside, London: Routledge, 1999
27. P. Rabinow, Making PCR: A Story of Biotechnology, Reprint Edition, Chicago: University of Chicago Press, 1997.
28. S. Bartholomew, "National Systems of Biotechnology Innovation: Complex Interdependence in the Global System," Journal of International Business Studies, 1997, vol. 28, 241-66
29. R.R. Nelson (ed.) National Innovation Systems: A Comparative Analysis, New York: Oxford University Press, 1993
30. M. Porter, The Competitive Advantage of Nations, New York: Free Press, 1990
31. C. Edquist "Systems of Innovation Approaches-Their Emergence and Character-istics," in C. Edquist (ed.) Systems of Innovation: Technologies, Institutions, and Organizations, London: Pinter, 1997
32. C. Freeman, "The 'National System of Innovation' in Historical Perspective," Cambridge Journal of Economics, 1995, vol. 19, 5-24
33. B. Steil, D.G. Victor, and R.R. Nelson, "Introduction and Overview," in B. Steil, D.G. Victor, and R.R. Nelson (eds) Technological Innovation and Economic Performance, Princeton: Princeton University Press, 2002.
34. M.E. Porter, H. Takeuchi, and M. Sakakibara, Can Japan Compete? Cambridge, MA: Perseus Publishing, 2000
35. H. Itami, Nihon sangyo mitsu no nami [Japanese Industry: Three Waves], Tokyo: NTT Shuppansha, 1998.
36. E. Mansfield, "Industrial R&D in Japan and the United States," American Economic Review, 1988, vol. 78, 223-8.
37. R. Rosenbloom and M. Cusumano, "Technological Pioneering and Competitive Advantage: The Birth of the VCR Industry," California Management Review, 1987, vol. 4, 51-75.
38. C. Johnson, MITI and the Japanese Miracle: The Growth of Industrial Policy, 1925-1975, Stanford, CA: Stanford University Press, 1982.
39. D.I. Okimoto, Between MITI and the Market: Japanese Industrial Policy for High Technology, Stanford, CA: Stanford University Press, 1989, p. 226.
40. S. Callon, Divided Sun: MITI and the Breakdown of Japanese High-Tech Industrial Policy, 1975-1993, Stanford, CA: Stanford University Press, 1995, p. 186.
41. L. Thurow, Head to Head: The Coming Economic Battle Among Japan, Europe, and America, New York: Morrow, 1992
42. J. Zysman, Governments, Markets, and Growth: Financial Systems and the Politics of Industrial Change, Ithaca, NY: Cornell University Press, 1983.
43. D.S. Greenberg, Science, Money, and Politics: Political Triumph and Ethical Erosion, Chicago: University of Chicago Press, 2001.
44. "Biotechnology: A Collection of Technologies," Biotechnology Industry Organization, online, available HTTP: (accessed 27 June 2003).
45. M. Morange, A History of Molecular Biology (Cambridge, MA: Harvard University Press, 1998), ch. 12.
46. P.A. Geroski, "Vertical Relations between Firms and Industrial Policy," The Economic Journal, 1992, vol. 102 (January), 138-47
47. D. Teece, "Strategies for Capturing the Financial Benefits of Technological Innovation," in N. Rosenberg et al. (eds) Technology and the Wealth of Nations, Stanford: Stanford University Press, 1992.
48. B.W. Arthur, "Self-Reinforcing Mechanisms in Economics," in K. Arrow and D. Pines (eds) The Economy as an Evolving Complex System, Reading, MA: Addison-Wesley, 1988
49. D. North, Institutions, Institutional Change, and Economic Performance, Cambridge: Cambridge University Press, 1990.
50. P.A. David, "Clio and the Economics of QWERTY," American Economic Review, 1985, vol. 76, 332-7.
51. W.J. Baumol, The Free-Market Innovation Machine, Princeton: Princeton University Press, 2001, ch. 1
52. V.W. Ruttan, Technology, Growth, and Development, New York: Oxford University Press, 2001, ch. 2.
53. I. Nonaka, N. Konno, and R. Toyama, "Emergence of 'Ba'," in I. Nonaka and T. Nishiguchi (eds) Knowledge Emergence: Social, Technical, and Evolutionary Dimensions of Knowledge Creation, New York: Oxford University Press, 2001.
54. A. Lam, "Tacit Knowledge, Organizational Learning and Societal Institutions: An Integrated Framework," Organization Studies, 2000, vol. 21, 487-513.
55. A.K. Klevorick et al., "On the Sources and Significances of Interindustry Differences in Technological Opportunities," Research Policy, 1995, vol. 24, 185-205.
56. R. Nelson and S.Winter, "In Search of a Useful Theory of Innovation," Research Policy, 1977, vol. 6, 36-76.
57. G. Dosi, "The Nature of the Innovative Process," in Dosi et al. (eds) Technical Change and Economic Theory, London: Pinter, 1988, p. 224.
58. C. Perez, "Microelectronics, LongWaves andWorld Structural Change: New Perspectives for Developing Countries," World Development, 1985, vol. 13, 441-63.
59. C. Freeman, "Technical Innovation in the World Chemical Industry and Changes of Techno-Economic Paradigm," in C. Freeman and L. Soete (eds) New Explorations in the Economics of Technical Change, London: Pinter, 1990.
60. H. Kitschelt, "Industrial Governance Structures, Innovation Strategies and the Case of Japan," International Organization, 1991, vol. 45, 453-93.
61. R. Nelson, "What is Commercial and What is Public about Technology, and What Should Be?" in N. Rosenberg et al. (eds) Technology and the Wealth of Nations, Stanford: Stanford University Press, 1992.
62. R. Levin et al., "Appropriating the Returns to Industrial R&D," Brookings Papers on Economic Activity, 1987, vol. 3.
63. K. Pavitt, "Sectoral Patterns of Technical Change," Research Policy, 1984, vol. 13, 343-73.
64. L.H. Lynn, N.M. Reddy, and J.D. Aram, "Linking Technology and Institutions: The Innovation Community Framework," Research Policy, 1996, vol. 25, 91-106.
65. S. Winter, "Knowledge and Competence as Strategic Assets," in D. Teece (ed.) The Competitive Challenge, Cambridge, MA: Ballinger Press, 1987, pp. 159-84.
66. W. Powell, "Learning from Collaboration: Knowledge and Networks in the Biotechnology and Pharmaceutical Industries," California Management Review, 1998, vol. 40 (Spring), 228-40
67. N. Greis, M. Dibner, and S. Alden, "External Partnering as a Response to Innovation Barriers and Global Competition in Biotechnology," Research Policy, 1995, vol. 24, 608-40.
68. N. Rosenberg, Perspectives on Technology, Cambridge: Cambridge University Press, 1976, p. 170.
69. H. Ergas, "Does Technology Policy Matter?" in B. Guile and H. Brooks (eds) Technology and Global Industry, Washington, DC: National Academy Press, 1987
70. N. Reingold, "The Peculiarities of the Americans or Are There National Styles in the Sciences?" Science in Context, 1991, vol. 4, 347-66
71. D. Mowery, "The US National Innovation System: Origins and Prospects for Change," Research Policy, 1992, vol. 21, 125-44
72. C. Edquist, "Systems of Innovation Approaches - Their Emergence and Characteristics," in C. Edquist (ed.) Systems of Innovation: Technologies, Institutions and Organizations, London: Pinter, 1997
73. R. Whitley, "The Institutional Structuring of Innovation Strategies: Business Systems, Firm Types and Patterns of Technical Change in Different Market Economies," Organization Studies, 2000, vol. 21, 855-86.
74. C. Freeman, Technology Policy and Economic Performance: Lessons from Japan, New York: Frances Pinter, 1987, p. 1.
75. C. Freeman, "Japan: A New National System of Innovation?" in Dosi et al. (eds) Technical Change and Economic Theory.
76. M. Porter, The Competitive Advantage of Nations, New York: Free Press, 1990.
77. S. Krimsky, Biotechnics and Society: The Rise of Industrial Genetics, New York: Praeger, 1991.
78. M. Kenney, Biotechnology: The University-Industrial Complex, New Haven: Yale University Press, 1986, ch. 7
79. Arthur Kornberg, The Golden Helix: Inside Biotech Ventures, Sausalito, CA: University Science Books, 1995, pp. 28-9.
80. L.G. Zucker, M.R. Darby, and M.B. Brewer, "Intellectual Human Capital and the Birth of US Biotechnology Enterprises," American Economic Review, March 1998, vol. 88, 290-306.
81. J. Cortright and H. Mayer, "Signs of Life: The Growth of Biotechnology Clusters in the U.S.," Brookings Institution, June 2002, online, available HTTP: (accessed 9 August 2002).
82. C. Robbins-Roth, From Alchemy to IPO: The Business of Biotechnology, Cambridge, MA: Perseus Publishing, 2000, p. 166.
83. G.S. Burrill, "Life Sciences: State of the Industry," June 2002, Burrill&Company, online, available HTTP: (accessed 4 July 2002).
84. W.W. Powell, "Learning from Collaboration: Knowledge and Networks in the Biotechnology and Pharmaceutical Industries," California Management Review, Spring 1998, pp. 228-40.
85. S. Nicholson, P.M. Danzon, and J. McCullough, "Biotech-Pharmaceutical Alliances as a Signal of Asset and Firm Quality," NBER Working Paper 9007, National Bureau of Economic Research, 2002.
86. M. McKelvey, Evolutionary Innovations, New York, Oxford University Press, 1996, p. 261.
87. Monbukagakusho, kenkyu shinkokyoku, raifusaiensuka, et al., "Heisei 13 nendo baiosangyo sozo kiso chosa hokokusho" [Report on the Basic Survey of Bioindustry Creation], March 2002, available HTTP: (accessed 16 November 2002).
88. M. Gerlach, Alliance Capitalism, Berkeley: University of California Press, 1992, ch. VI.
89. Kosei Rodosho, "'Seimei no seiki' o sasaeru iyakuhin sangyo no kokusai kyosoryoku kyoka ni mukete: Iyakuhin sangyo bijion no gaiyo" [Strengthening the International Competitiveness of the Pharmaceutical Industry to Support the Century of Life: Outline of the Vision for the Pharmaceutical Industry], 30 August 2001, p. 5.
90. C. Oberlander, "R&D in Japan's Pharmaceutical Industry," in M. Hemmert and C. Oberlander (eds) Technology and Innovation in Japan, London and New York: Routledge, 1998, p. 180.
91. M. Reich, "Why the Japanese Don't Export More Pharmaceuticals: Health Policy as Industrial Policy," California Management Review, Winter 1990, 124-50.
92. R. Henderson, L. Orsenigo, and G. Pisano, "The Pharmaceutical Industry and the Revolution in Biotechnology," in D. Mowery and R. Nelson (eds) Sources of Industrial Leadership, New York: Cambridge University Press, 1999, p. 282.
93. J. Paugh and J.C. Lafrance, "Meeting the Challenge: US Industry Faces the Twenty-first Century-The US Biotechnology Industry," US Department of Commerce, Office of Technology Policy, July 1997, pp. 68-70.
94. D. Guston, "Technology Transfer and CRADAs at the NIH," in L. Branscomb and J. Keller (eds) Investing in Innovation, Cambridge: MIT Press, 1999, pp. 221-49
95. R. Kneller, "Technology Transfer: A Review for Biomedical Researchers," Clinical Cancer Research, 2001, vol. 7, April, pp. 761-74.
96. R. Evenson, "Agriculture," in R. Nelson (ed.) Government and Technical Progress, New York: Pergamon, 1982.
97. N. Rosenberg and R. Nelson, "American Universities and Technical Advance in Industry," Research Policy, 1994, vol. 23, 323-48.
98. R. Landau and N. Rosenberg, "Successful Commercialization in the Chemical Process Industry," in N. Rosenberg et al. (eds) Technology and the Wealth of Nations, Stanford: Stanford University Press, 1992, pp. 85-93.
99. R. Nelson, "The Rise and Fall of American Technological Leadership: The Postwar Era in Historical Perspective," Journal of Economic Literature, December 1992, vol. XXX, p. 1951.
100. D. Blumenthal, N. Causino, E. Campbell, and K.S. Louis, "Relationships between Academic Institutions and Industry in the Life Sciences," The New England Journal of Medicine, 8 February 1996, vol. 334, 368-73.
101. F. Narin, K.S. Hamilton, and D. Olivastro, "The Increasing Linkage between U.S. Technology and Public Science," Research Policy, 1997, vol. 26, 317-30
102. G.S. McMillan, F. Narin, and D.L. Deeds, "An Analysis of the Critical Role of Public Science in Innovation: The Case of Biotechnology," Research Policy, 2000, vol. 29, 1-8.
103. D.C. Mowery, R.R. Nelson, B.N. Sampat, and A.A. Ziedonis, "The Growth of Patenting and Licensing by U.S. Universities: An Assessment of the Effects of the Bayh-Dole Act of 1980," Research Policy, 2001, vol. 30, 99-119.
104. L.G. Zucker and M.R. Darby, "Star Scientists and Institutional Transformation: Patterns of Invention and Innovation in the Formation of the Biotechnology Industry," Proceedings of the National Academy of Sciences of the United States of America, 12 November 1996, vol. 93, 12709-16.
105. J. Cortright and H. Mayer, "Signs of Life: The Growth of Biotechnology Clusters in the U.S.," Brookings Institution, June 2002, online, available HTTP: (accessed 9 August 2002).
106. T. Morris-Suzuki, The Technological Transformation of Japan, Cambridge: Cambridge University Press, 1994, p. 99.
107. Mitsubishi Sogo Kenkyusho, Genomu bijinesu [Genome Business], Tokyo: Mitsubishi Sogo Kenkyusho, 2001, pp. 22-7.
108. A. Saegusa, "Japan's Genome Program Goes Ahead, with Protein Analysis," Nature, 19 March 1998, p. 219
109. D. Cyranoski, "Japan Speeds up Mission to Unravel Genetic Diseases," Nature, 26 April 2001, p. 1013.
110. Y. Miyata, Amerika no sangaku renkei [University-Industry Relations in the US], Tokyo: Toyo Keizai Shinposha, 2002, p. 211.
111. S. Collins and H. Wakoh, "Universities and Technology Transfer in Japan," Journal of Technology Transfer, vol. 25, 2000, 213-22.
112. S. Yamamoto, "The Role of the Japanese Higher Education System in Relation to Industry," in A. Goto and H. Odagiri (eds) Innovation in Japan, New York: Clarendon Press, 1997, pp. 295-301.
113. B. Barker, "Internationalizing Japanese Science," in Technology and Innovation in Japan, p. 76.
114. S. Coleman, Japanese Science from the Inside, London: Routledge, 1999, pp. 10-12.
115. R. Kneller, "Intellectual Property Rights and University-Industry Technology Transfer in Japan," in Branscomb and Kodama (eds) Industrializing Knowledge, p. 315.
116. V. Bush, Science: The Endless Frontier, Washington, DC: Government Printing Office, 1945, pp. 14-15.
117. D. Mowery, "U.S. National System of Innovation," in R. Nelson (ed.) National Innovation Systems: A Comparative Analysis, New York: Oxford University Press, 1992, pp. 39-52
118. A. Teich and J. Pace, Science and Technology in the U.S.A., London: Longman, 1986, pp. 25-7.
119. D.S. Greenberg, Science, Money, and Politics, Chicago: University of Chicago Press, 2001, p. 426.
120. Lisa Raines, "Protecting Biotechnology's Pioneers," Issues in Science and Technology, Winter 1991/92, pp. 33-9.
121. Reid Adler, "Genome Research: Fulfilling the Public's Expectations for Knowledge and Commercialization," Science, 14 August 1992, 908-14
122. Y. Tanaka and R. Hirasawa, "Features of Policy Making Processes in Japan's Council for Science and Technology," Research Policy, 1996, vol. 25, 999-1011.
123. C. Johnson, "MITI, MPT, and the Telecom Wars," in C. Johnson et al. (eds) Politics and Productivity, Cambridge: Ballinger, 1989.
124. J. Lewis, "Collision of Interests: The Role of the Ruling Party in Science and Technology Policy," Japan Forum, 1994, vol. 6, 62-72.
125. Y.S. Lee, K. Kitazawa, and S. Nakayama, "A Radical Restructuring of Japan's Postwar Science and Technology Policy and Institutions: The Politics and Rationality of the New Century," NSF Report Memorandum #00-08, 15 May 2000, online, available HTTP: (accessed 3 June 2003).
126. B. Achilladelis, "Innovation in the Pharmaceutical Industry," in R. Landau, B. Achilladelis, and A. Scriabine (eds) Pharmaceutical Innovation, Philadelphia: Chemical Heritage Press, 1999, ch. 1.
127. W. Kingston, "Antibiotics, Invention and Innovation," Research Policy, 2000, vol. 29, 679-710.
128. J. Drews, In Quest of Tomorrow's Medicines, New York: Springer-Verlag, 1999, p. 83.
129. M. Morange, A History of Molecular Biology, Cambridge, MA: Harvard University Press, 1998, chs 7-8.
130. H. Gottweis, Governing Molecules: The Discursive Politics of Genetic Engineering in Europe and the United States, Cambridge, MA: MIT Press, 1998, p. 74.
131. D.C. Mowery and N. Rosenberg, Technology and the Pursuit of Economic Growth, New York: Cambridge University Press, 1989, p. 93.
132. A.J. Morin, Science Policy and Politics, Englewood Cliffs, NJ: Prentice-Hall, 1993, p. 52
133. M. Kenney, Biotechnology: The University-Industrial Complex, New Haven: Yale University Press, 1986, pp. 14-15.
134. S. Wright, Molecular Politics, Chicago: University of Chicago Press, 1994, p. 24.
135. R. Teitleman, Gene Dreams: Wall Street, Academia, and the Rise of Biotechnology, New York: Basic Books, 1989, p. 17.
136. S. Olson, Biotechnology: An Industry Comes of Age, Washington, DC: National Academy Press, 1986, pp. 98-9.
137. H.F. Judson, "A History of the Science and Technology Behind Gene Mapping and Sequencing," in D.J. Kevles and L. Hood (eds) The Code of Codes, Cambridge: Harvard University Press, 1992
138. J. Watson, The DNA Story, San Francisco: Freeman Press, 1981
139. J. Watson, DNA: The Secret of Life, New York: Alfred A. Knopf, 2003, p. 85.
140. H.F. Judson, "A History of the Science and Technology Behind Gene Mapping and Sequencing," pp. 65-78.
141. S. Krimsky, Biotechnics and Society: The Rise of Industrial Genetics, New York: Praeger, 1991, p. 197.
142. C. Robbins-Roth, From Alchemy to IPO: The Business of Biotechnology, Cambridge, MA: Perseus Publishing, 1999, pp. 13-14.
143. L.C. Plein, "Biotechnology: Issue Development and Evolution," in D.J. Webber (ed.) Biotechnology: Assessing Social Impacts and Policy Implications, New York: Greenwood Press, 1990, pp. 148-55.
144. L. Busch,W.L. Lacy, J. Burkhardt, and L. Lacy, Plants, Power, and Profit: Social, Economic, and Ethical Consequences of the New Biotechnologies, Oxford: Basil Blackwell, 1991, ch. 7.
145. J. Perpich, "Genetic Engineering and Related Biotechnologies: Scientific Progress and Public Policy," in J. Perpich (ed.) Biotechnology in Society, New York: Pergamon, 1986, pp. 90-2
146. Krimsky, Biotechnics and Society, pp. 101-2.
147. S. Wright and D.A. Wallace, "Varieties of Secrets and Secret Varieties: The Case of Biotechnology," Politics and the Life Sciences, 2000, vol. 19, 45-57.
148. P. Daly, The Biotechnology Business: A Strategic Analysis, London: Pinter, 1985, pp. 81-2
149. G. Steven Burrill, Biotech '89: Commercialization, New York: Mary Ann Liebert, 1998, p. 37.
150. D. Mowery, "The U.S. National Innovation System," in R. Nelson (ed.) National Systems of Innovation: A Comparative Analysis, New York: Oxford University Press, 1992, pp. 53-4.
151. R. Landau and N. Rosenberg, "Successful Commercialization in the Chemical Process Industries," in N. Rosenberg, R. Landau, and D. Mowery (eds) Technology and the Wealth of Nations, Stanford: Stanford University Press, 1992, pp. 73-117.
152. R. Florida and M. Kenney, The Breakthrough Illusion, New York: Basic Books, 1990, p. 57.
153. P. Huber, "Biotechnology and the Regulatory Hydra," Technology Review, November/December 1987, pp. 57-65.
154. Tom Harkin, "Biotechnology in Agriculture and America's Competitiveness," Policy Studies Journal, 1988, vol. 17, 68-72.
155. R. Cook-Deegan, The Gene Wars: Science, Politics, and the Human Genome, New York: W.W. Norton, 1994, especially ch. 12.
156. W. Kaplan, "Biotech Patenting 101," Council for Responsible Genetics, online, available HTTP: (accessed 19 June 2003).
157. K. Davies, Cracking the Genome, New York: The Free Press, 2001, p. 66.
158. M. Hongo, Nihon no baiteku choryu: shindai kara gendai o koete [Trends in Japan's Biotechnology: From the Age of the Gods to Modern Times], Tokyo: HBJ Shuppankyoku, 1988, pp. 4-6.
159. M. Tanimoto, "Juzogyo" [Brewing], in S. Nishikawa, K. Odaka, and O. Saito (eds) Nihon keizai no 200 nen [200 Years of Japan's Economy], Tokyo: Nihon Hyoronsha, 1996, p. 255
160. I. Karube, Baio no hanashi: nogyo kara erekutoronikusu made nyu baiogijutsu ga hiraku kanosei [The Biotechnology Story: The Potential of New Biotechnology from Agriculture to Electronics], Tokyo: Nihon Jitsugyo Shuppansha, 1991, pp. 20-1.
161. T. Morris-Suzuki, The Technological Transformation of Japan, New York: Cambridge University Press, 1994, pp. 102-3.
162. M. Brock, Biotechnology in Japan, London: Routledge, 1989, p. 30.
163. H. Lewis, "Biotechnology in Japan," Scientific Bulletin, April-June 1985, Department of the Navy, Office of Naval Research Far East, p. 13.
164. H. Katayama, "Biotech Unbound," Business Tokyo, September 1991, p. 23.
165. J. Bailey and D. Ollis, Biochemical Engineering Fundamentals, New York: McGraw-Hill, 1981, pp. 605-7.
166. T. Ohta and K. Ishii, Baiobijinesu no shikumi [Organization of Biotechnology Business], Tokyo: Toyo Keizai Shimposha, 2002, pp. 108-118.
167. K. Yoshitaro, "Kogyo bunya ni okeru baio no oyo: biaoriakutaa o chushin toshite" [Biotechnology Applications in Manufacturing: Focus on Bioreactors], Purometiusu, March-April 1987, pp. 40-3.
168. J.R. Bartholomew, The Formation of Science in Japan, New Haven: Yale University Press, 1989, pp. 51-2.
169. S. Sugiyama, Nihon no kindai kagakushi [Recent History of Science in Japan], Tokyo: Asakura Shoten, 1994, pp. 94-5, 107.
170. S. Coleman, Japanese Science From the Inside, New York: Routledge, 1999, p. 120.
171. Nikkei Sangyo Shimbun, Seimei sangyo jidai: Baiotekunorojii no shogeki [The Era of Bio-Industry: Biotechnology Shock], Tokyo: Nihonkeizai shimbunsha, 1981, p. 164.
172. I. Hiroyuki, Nihon no kagaku sangyo: naze sekai ni tachiokureta no ka [Japan's Chemical Industry: Why It Lags the Rest of the World], Tokyo: NTT Shuppansha, 1991, pp. 83-5.
173. Kodama Fumio, Kyodo kenkyu ni okeru sanka kigyo ni kansuru chosakenkyu [Survey Research of Companies Participating in Cooperative Research], Kenkyu gijutsu keikaku, 1990, vol. 5, pp. 30-50.
174. T. Kaminuma and G. Matsumoto, Biocomputers: The Next Generation from Japan, New York: Chapman & Hall, 1991, pp. 114-16
175. Edward Roberts and Ryosuke Mizouchi, "Inter-firm Technological Collaboration: The Case of Japanese Biotechnology," International Journal of Technology Management, 1989, vol. 4, 43-61.
176. Chalmers Johnson, "MPT, MITI and the Telecom Wars," in C. Johnson, L. Tyson, and J. Zysman (eds) Politics and Productivity: The Real Story of Why Japan Works, Cambridge: Ballinger, 1989.
177. R. Cook-Deegan, The Gene Wars: Science, Politics, and the Human Genome, New York: W.W. Norton, 1994, pp. 219-20.
178. R. Landau and N. Rosenberg, "Successful Commercialization in the Chemical Process Industries," in N. Rosenberg et al. (eds) Technology and the Wealth of Nations, Stanford: Stanford University Press, 1992.
179. R. Florida and M. Kenney, The Breakthrough Illusion, New York: Basic Books, 1990.
180. F. Kodama, "Technology Fusion and the New R&D," Harvard Business Review, July-August 1992, pp. 70-8.